Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC
Clinical trial NCT02987998 · TERMINATED
Trial details
- NCT number
- NCT02987998
- Sponsor
- Nathan Pennell, MD, PhD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-19
- Primary completion
- 2022-11-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.